Mounjaro 5mg sulphur burps: the myth, the mechanism, and what actually helps

The myth: sulphur burps mean the medicine is not working, or that something is wrong

This is the most common misconception our prescribers hear. People move from 2.5mg to 5mg, notice a wave of bloating and eggy belching, and worry they have had a bad reaction. In almost every case, the opposite is true: the symptom is evidence that tirzepatide is doing exactly what it is supposed to do.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. One of its central effects is slowing gastric emptying — food lingers in the stomach longer than usual, which is part of how the medicine reduces appetite and calorie intake. That slower transit gives bacteria in the upper gut a longer window to ferment sulphur-containing compounds from food, producing hydrogen sulphide gas. Eggy burps are, in a slightly inelegant way, a sign of pharmacological activity. The NHS medicines page for tirzepatide lists gastrointestinal symptoms (nausea, bloating, indigestion, burping) among the most commonly reported effects, particularly after starting treatment or increasing the dose.

The 5mg step is the first dose at which most people experience meaningful appetite suppression. It is also, not coincidentally, the first dose where GI side effects tend to announce themselves more loudly. Understanding that the symptom has a cause (and that the cause is temporary and manageable) is genuinely useful. Panic and reassurance are both unwarranted; practical action is.

Why the 5mg dose is the flashpoint for this symptom

The 2.5mg starter dose is designed primarily for tolerability. It gives the body four weeks to adjust to the mechanism before the dose climbs. For many people, those first four weeks pass without much drama. Then 5mg arrives and the GI system notices.

The step up intensifies gastric slowing, which means food (particularly high-sulphur food) spends even longer fermenting before it moves on. Eggs, red meat, garlic, onions, leeks, broccoli, cauliflower, and cabbage are the main culprits. If your diet contains several of these and you have just moved onto the 5mg dose, the combination is predictable.

Timing matters too. Eating a large meal in the evening (when digestion is already slower) tends to make things worse overnight or first thing in the morning. A question worth asking is whether the symptom is worse on certain days: the answer usually maps onto what was eaten the day before. One practical detail: if you take your weekly injection on a Monday, your peak sulphur-burp window is often the following Thursday or Friday, when the dose is reaching higher plasma levels. Adjusting meal composition in that window can make a real difference before the body settles.

It is worth reading the patient information leaflet that comes with the Mounjaro KwikPen; it lists the GI effects and confirms they are expected, particularly early in treatment or after titration.

What actually helps, and when to speak to a clinician

There is no single fix, but several strategies consistently reduce the severity of sulphur burps on Mounjaro 5mg. The most effective changes are dietary.

Cutting back on high-sulphur foods for the first two to three weeks at 5mg is the simplest starting point. This does not mean eliminating eggs or vegetables permanently (protein adequacy matters on GLP-1 treatment) but reducing portion size and frequency during the adjustment period is sensible. Eating smaller meals more slowly, chewing thoroughly, and avoiding carbonated drinks all reduce the volume of gas produced. Staying well hydrated helps gut transit generally.

Some people find that peppermint tea or ginger helps with the associated nausea; these are low-risk additions, though the evidence base is anecdotal rather than clinical. There is no over-the-counter medicine specifically indicated for sulphur burps, and antacids address acid rather than gas, so they tend not to help much.

If you are managing costs alongside treatment, understanding how Mounjaro pricing works in the UK can clarify what ongoing treatment involves. More importantly, though: if sulphur burps are severe, if they are accompanied by persistent vomiting or significant nausea that stops you eating, or if you develop severe abdominal pain that radiates to your back, those symptoms go beyond adjustment and need medical assessment. The MHRA's Yellow Card scheme allows you and your clinician to report side effects formally, which also helps the wider safety monitoring of newer medicines. Similarly, symptoms that do not improve within two to three weeks at 5mg are worth discussing with your prescriber rather than waiting out alone. The next titration step, the 7.5mg dose, introduces a further increase in gastric slowing, knowing what to expect and having a dietary plan in place makes that transition easier.

If you are considering starting tirzepatide or are mid-treatment and want clinical input, our prescribers review consultations the same working day. Start your free consultation and a real clinician (not automated software) reads your answers and responds.